Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Wester

Showing results (81-90 of 119) with videos related to

Pageof 12
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1997
Cloning, expression and pharmacological characterization of rabbit adenosine A1 and A3 receptorsR J Hill, J J Oleynek, C F Hoth, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Discovery of inhibitors of human renin with high oral bioavailabilityD J Hoover, B A Lefker, R L Rosati, et al.
BJS Open|July 14, 2020
Total colonic aganglionosis: multicentre study of surgical treatment and patient-reported outcomes up to adulthoodP Stenström, K Kyrklund, M Bräutigam, et al.
Orbit (Amsterdam, Netherlands)|April 25, 2020
Thyroid eye disease with choroidal foldsAnn Q Tran, Sandy X Zhang-Nunes, Kenneth Cahill, et al.
European Journal of Pharmacology|September 12, 2002
Zoniporide: a potent and highly selective inhibitor of human Na(+)/H(+) exchanger-1Ravi B Marala, Janice A Brown, Jimmy X Kong, et al.
Ophthalmic Plastic and Reconstructive Surgery|December 10, 2024
Surgical Timing for Patients With Thyroid Eye Disease Treated With Teprotumumab: A Collaborative Multicenter StudyHannah L Walsh, Kevin D Clauss, Benjamin I Meyer, et al.
The Journal of Clinical Endocrinology and Metabolism|November 5, 2023
Efficacy and Safety of Teprotumumab in Patients With Thyroid Eye Disease of Long Duration and Low Disease ActivityRaymond S Douglas, Steven Couch, Sara T Wester, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 24, 2004
Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapibRonald W Clark, Tamara A Sutfin, Roger B Ruggeri, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2001
A novel sodium-hydrogen exchanger isoform-1 inhibitor, zoniporide, reduces ischemic myocardial injury in vitro and in vivoD R Knight, A H Smith, D M Flynn, et al.
Ophthalmology|October 18, 2023
Teprotumumab-Related Adverse Events in Thyroid Eye Disease: A Multicenter StudyShreya A Shah, Linus Amarikwa, Connie M Sears, et al.
Pageof 12

Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1997
Cloning, expression and pharmacological characterization of rabbit adenosine A1 and A3 receptorsR J Hill, J J Oleynek, C F Hoth, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Discovery of inhibitors of human renin with high oral bioavailabilityD J Hoover, B A Lefker, R L Rosati, et al.
BJS Open|July 14, 2020
Total colonic aganglionosis: multicentre study of surgical treatment and patient-reported outcomes up to adulthoodP Stenström, K Kyrklund, M Bräutigam, et al.
Orbit (Amsterdam, Netherlands)|April 25, 2020
Thyroid eye disease with choroidal foldsAnn Q Tran, Sandy X Zhang-Nunes, Kenneth Cahill, et al.
European Journal of Pharmacology|September 12, 2002
Zoniporide: a potent and highly selective inhibitor of human Na(+)/H(+) exchanger-1Ravi B Marala, Janice A Brown, Jimmy X Kong, et al.
Ophthalmic Plastic and Reconstructive Surgery|December 10, 2024
Surgical Timing for Patients With Thyroid Eye Disease Treated With Teprotumumab: A Collaborative Multicenter StudyHannah L Walsh, Kevin D Clauss, Benjamin I Meyer, et al.
The Journal of Clinical Endocrinology and Metabolism|November 5, 2023
Efficacy and Safety of Teprotumumab in Patients With Thyroid Eye Disease of Long Duration and Low Disease ActivityRaymond S Douglas, Steven Couch, Sara T Wester, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 24, 2004
Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapibRonald W Clark, Tamara A Sutfin, Roger B Ruggeri, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2001
A novel sodium-hydrogen exchanger isoform-1 inhibitor, zoniporide, reduces ischemic myocardial injury in vitro and in vivoD R Knight, A H Smith, D M Flynn, et al.
Ophthalmology|October 18, 2023
Teprotumumab-Related Adverse Events in Thyroid Eye Disease: A Multicenter StudyShreya A Shah, Linus Amarikwa, Connie M Sears, et al.
Pageof 12